Registration statement

Medicenna Announces the Launch of a Marketed Underwritten Public Offering of Units

Retrieved on: 
Monday, August 8, 2022 - 9:15pm

TORONTO and HOUSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (Medicenna or theCompany) (Nasdaq: MDNA, TSX: MDNA), a clinical stage immunotherapy company, announced today the launch of a marketed underwritten public offering of units of the Company (the Units) in the United States (theOffering).

Key Points: 
  • TORONTO and HOUSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (Medicenna or theCompany) (Nasdaq: MDNA, TSX: MDNA), a clinical stage immunotherapy company, announced today the launch of a marketed underwritten public offering of units of the Company (the Units) in the United States (theOffering).
  • The Offering is expected to be priced in the context of the market, with the final terms of the Offering to be determined at the time of pricing.
  • There can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
  • Guggenheim Securities, LLC is acting as sole book-running manager for the Offering.

MISSFRESH LIMITED (NASDAQ: MF) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Missfresh Limited (NASDAQ: MF)

Retrieved on: 
Monday, August 8, 2022 - 9:00pm

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired the securities of Missfresh Limited (“Missfresh” or the “Company”) (NASDAQ: MF) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Missfresh’s June 2021 initial public offering (the “IPO” or “Offering”). The lawsuit was filed in the United States District Court for the Eastern District of New York and alleges violations of the Securities Exchange Act of 1933.

Key Points: 
  • If so, please visit Missfresh Limited Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Eastern District of New York and alleges violations of the Securities Exchange Act of 1933.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

MOLECULAR PARTNERS AG (NASDAQ: MOLN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Molecular Partners AG (NASDAQ: MOLN)

Retrieved on: 
Monday, August 8, 2022 - 9:00pm

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired: (a) Molecular Partners AG (“Molecular Partners” or the “Company”) American Depositary Shares (“ADSs”) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about June 16, 2021 (the “IPO”); and/or (b) Molecular Partners securities between June 16, 2021 and April 26, 2022, both dates inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Act of 1933 and Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Molecular Partners AG Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • Molecular Partners operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic proteins.
  • Among other product candidates, Molecular Partners is developing ensovibep as a treatment for COVID-19 in collaboration with Novartis AG (Novartis).
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

WEBER INC. (NYSE: WEBR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Weber Inc. (NYSE: WEBR)

Retrieved on: 
Monday, August 8, 2022 - 9:00pm

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired the Class A common stock of Weber Inc. (“Weber” or the “Company”) (NYSE: WEBR) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s August 2021 initial public offering (“IPO” or the “Offering”). The lawsuit was filed in the United States District Court for the Northern District of Illinois and alleges violations of the Securities Exchange Act of 1933.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Northern District of Illinois and alleges violations of the Securities Exchange Act of 1933.
  • Weber is an outdoor cooking company that sells grills, smokers, grilling accessories, and solid fuel products across the world.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Missfresh Limited (MF)

Retrieved on: 
Monday, August 8, 2022 - 5:00pm

In June 2021, Missfresh held its IPO, selling 21 million American Depository Shares (ADSs) at $13 per ADS.

Key Points: 
  • In June 2021, Missfresh held its IPO, selling 21 million American Depository Shares (ADSs) at $13 per ADS.
  • On this news, Missfreshs stock fell 13%, to close at $0.448 per ADS on May 2, 2022, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Weber Inc. (WEBR) Investors of Class Action and to Actively Participate

Retrieved on: 
Monday, August 8, 2022 - 2:52pm

A class action lawsuit has already been filed.

Key Points: 
  • A class action lawsuit has already been filed.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.
  • If you suffered a loss in Weber you have until September 27, 2022, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

Novibet Provides Update on North America Expansion Strategy Including Recent Agreement With Caesars Entertainment Granting Company New Jersey Market Access for iGaming and Online Sports Betting

Retrieved on: 
Monday, August 8, 2022 - 1:30pm

Novibet today announced a new multi-year market access agreement with Caesars Entertainment, providing Novibet the opportunity to conduct online sports betting (OSB) and iGaming operations in New Jersey.

Key Points: 
  • Novibet today announced a new multi-year market access agreement with Caesars Entertainment, providing Novibet the opportunity to conduct online sports betting (OSB) and iGaming operations in New Jersey.
  • Pursuant to the terms of the agreement, Novibet will operate a branded online gambling service (including OSB and iGaming) in New Jersey for ten years.
  • Big Bola is one of only 14 operators authorized to offer legal betting and online casino services in Mexico.
  • Novibet also provided an update on its efforts to enter the Ontario, Canada online market which opened in April 2022.

Gainey McKenna & Egleston Announces It Has Filed A Class Action Lawsuit Against Kiromic BioPharma, Inc. (KRBP)

Retrieved on: 
Saturday, August 6, 2022 - 4:30am

NEW YORK, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it has filed a class action lawsuit against Kiromic BioPharma, Inc. (Kiromic or the Company) (NASDAQ: KRBP) and against certain officers and directors of the Company.

Key Points: 
  • NEW YORK, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it has filed a class action lawsuit against Kiromic BioPharma, Inc. (Kiromic or the Company) (NASDAQ: KRBP) and against certain officers and directors of the Company.
  • Plaintiff pursues claims against Defendants under the Securities Act of 1933 and the Securities Exchange Act of 1934.
  • If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq.
  • of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at tjmckenna@gme-law.com or gegleston@gme-law.com .

INVESTOR DEADLINE: Investors in Weber Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – WEBR

Retrieved on: 
Saturday, August 6, 2022 - 4:58am

22-cv-03966 (N.D. Ill.), the Weber class action lawsuit charges Weber, certain of its top executives and directors, and the IPOs underwriters with violations of the Securities Act of 1933.

Key Points: 
  • 22-cv-03966 (N.D. Ill.), the Weber class action lawsuit charges Weber, certain of its top executives and directors, and the IPOs underwriters with violations of the Securities Act of 1933.
  • A lead plaintiff acts on behalf of all other class members in directing the Weber class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Weber class action lawsuit.
  • An investors ability to share in any potential future recovery of the Weber class action lawsuit is not dependent upon serving as lead plaintiff.

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Weber Inc. (WEBR)

Retrieved on: 
Friday, August 5, 2022 - 6:00pm

Investors suffering losses on their Weber investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .

Key Points: 
  • Investors suffering losses on their Weber investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • On or about August 6, 2021, the Company completed its IPO, selling approximately 17,857,143 shares of Class A common stock at a price of $14.00 per share.
  • On July 25, 2022, before the market opened, Weber announced its preliminary third quarter 2022 financial results, including net sales between $525 million and $530 million.
  • Additionally, Weber announced that Chris Scherzinger is departing from his roles as Chief Executive Officer and director of the Company.